Indian Army Medical Supplies Tender Senapati Manipur 795007 2025 for Tablets, Rotacaps, Nasal Spray & Related Drugs

Tender Overview

Organization: Indian Army (Department Of Military Affairs) seeks supply of pharmaceutical and allied products at SENAPATI, MANIPUR 795007. The scope covers 34 items including Tabs, Rotacaps, Nasal Sprays and other medicinal formulations such as Rosuvastatin combinations, Quetiapine, Calcitonin nasal spray, and Detergent-like SA. The BOQ lists 34 items, with no explicit unit quantities provided. The tender includes an option clause enabling up to 25% quantity variation at contracted rates and a delivery-time framework linked to last delivery order date. Significant emphasis on financial due diligence is shown via turnover requirements for bidders and OEMs, plus a warranty/service SLA component. The procurement aims at ensuring timely servicing with dedicated technical staff during the warranty period. Unique aspects include the dual consideration of bidder and OEM turnover and a service-delivery SLA requirement.

This opportunity targets suppliers with relevant pharmaceutical manufacturing or distribution capabilities and requires adherence to contractually defined delivery timelines, quantity flexibilities, and after-sales service commitments.

Technical Specifications & Requirements

• Product names/categories: tablets and caplets (e.g., Rosuvastatin‑based combinations, Quetiapine 50 mg/other listed formulations), Rotacaps (Salmeterol+Fluticasone; Formeterol+Budesonide), Nasal spray (Calcitonin), Purgative powders, Glucose/Haematinic syrups, and other listed compounds.
• Scope indicators: 34 items across multiple therapeutic classes; no explicit unit quantities disclosed in the available data.
• Standards/Compliance: Not specified in the provided data; bidders should verify required pharmacopoeial or regulatory standards in the bid documents.
• Delivery/Installation: Delivery terms tied to last delivery order date; optioned quantities will follow calculated time extensions per formula.
• Warranty/Support: Service personnel deployed for timely servicing and defect rectification during warranty, per SLA terms in the bid.
• Experience/Capabilities: OEM turnover criteria apply; bidders must demonstrate adequate turnover and capability to supply pharmaceutical products.

Terms, Conditions & Eligibility

• Option Clause: Quantity may be increased/decreased by up to 25% of bid/contract quantity; extended delivery times apply with a minimum of 30 days for additional quantities.
• Turnover requirements: Minimum average annual turnover over last three years (ending 31 March of the previous year) for both bidders and OEMs as specified in the bid document; documented via audited accounts or CA/Cost Accountant certificates.
• Warranty/Service: Dedicated technical service personnel deployed to address service requests under a defined SLA during warranty.
• Documentation: Bidders must attach turnover proofs and OEM authorizations; contract terms emphasize service readiness and timely rectification.
• Penalties/Payments: Details not provided here; bidders should consult the bid document for payment terms and LD clauses.